Improving the Treatment for Women With Early Stage Cancer of the Uterus

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

165

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

October 3, 2022

Study Completion Date

December 31, 2026

Conditions
Complex Endometrial Hyperplasia With AtypiaGrade 1 Endometrial Endometrioid Adenocarcinoma
Interventions
DRUG

Levonorgestrel

Intrauterine device

DRUG

Metformin

oral medication

Trial Locations (17)

1023

Auckland City Hospital, Auckland

2025

Middlemore Hospital, Auckland

2050

Chris O'Brien Lifehouse, Camperdown

3053

Royal Women's Hospital, Carlton

3168

Monash Medical Centre, Clayton

4029

Royal Brisbane and Women's Hospital, Brisbane

4066

The Wesley Hospital, Auchenflower

4101

Mater Health Services, Brisbane, South Brisbane

Mater Private Hospital, South Brisbane

4120

Greenslopes Private Hospital, Greenslopes

4215

Gold Coast Hospital, Southport

4810

Townsville Hospital, Townsville

5000

Royal Adelaide Hospital, Adelaide

6008

King Edward Memorial Hospital for Women, Perth

6904

St John of God Hospital, Subiaco

Unknown

Christchurch Women's Hospital, Christchurch

Wellington Hospital, Wellington

All Listed Sponsors
collaborator

The University of Queensland

OTHER

collaborator

Queensland University of Technology

OTHER

lead

Queensland Centre for Gynaecological Cancer

OTHER_GOV

NCT01686126 - Improving the Treatment for Women With Early Stage Cancer of the Uterus | Biotech Hunter | Biotech Hunter